John Galgiani, MD

  • Director, Valley Fever Center for Excellence
  • Professor, BIO5 Institute
  • Professor, Medicine

John N. Galgiani, MD, a professor of medicine in infectious diseases at the University of Arizona College of Medicine – Tucson, has been working with Valley Fever (Coccidioidomycosis) for more than three decades. In 1996, he became founding director of the UA Valley Fever Center for Excellence, which was established by the Arizona Board of Regents for the benefit of the entire state. The center is located on the UA Health Sciences campus in Tucson and housed along with Dr. Galgiani’s lab at the UA BIO5 Institute. Its work encompasses public awareness, clinical guidelines and training, and research into rapid detection methods for the disease as well as collaborative efforts toward development of a vaccine for both animals and humans. Dr. Galgiani earned his undergraduate degree in biology from Stanford University and his medical degree from Northwestern University. He did a internship in internal medicine at Virginia Mason Hospital in Seattle and completed his residency at Santa Clara Valley Medical Center in San Jose, Calif., as well as a fellowship in infectious diseases at Stanford. He served as chief resident at Pacific Presbyterian Medical Center in San Francisco, before joining the faculty at the UA College of Medicine in 1978. He also was infectious diseases program director at the Southern Arizona VA Health Care System from then until 2009. Since 1975, Dr. Galgiani has been a member of the Coccidioidomycosis Study Group—an academic organization created in San Francisco in 1956 to research what was then known as San Joaquin Valley Fever—and has served as lead author for the Infectious Diseases Society of America’s “Clinical Practice Guideline for the Treatment of Coccidioidomycosis” in 2005 and 2016. Since 1981, he also has been associated with the National Institutes of Health’s Mycoses Study Group and remains a member of the Scientific Working Group for Biological and Emerging Infection Resources at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Dr. Galgiani has written more than 200 papers and articles relevant to fungal infections, their health consequences and treatment. He also sees patients at the Valley Fever Clinic at Banner – University Medical Center Tucson.

Research Interests: 

Valley Fever Infection control Coccidioidomycosis

Degrees
  • MD: Northwestern University, 1972
  • BA: Biology, Stanford University, Palo Alto, Calif., 1968
Honors and Awards
  • Voted "Best Doctors in America," 2009-2010
  • Affiliate, American College of Physicians
  • Affiliate, Coccidioidomycosis Study Group (1975 - )
  • Affiliate, Infectious Disease Society of America
  • Affiliate, Medical Mycology Society of the Americas
  • Affiliate, National Committee for Clinical Laboratory Standards
  • Affiliate, Western Society for Clinical Investigation
  • Affiliate, American Academy of Microbiology
  • Chief Resident, Pacific Presbyterian Medical Center, San Francisco, 1976-78
Residency
  • Santa Clara Valley Medical Center, Internal Medicine, 1974
Internship
  • Internal Medicine, Virginia Mason Hospital, Seattle, 1972-73
Fellowship
  • Infectious Diseases, Stanford University, Palo Alto, Calif., 1974-76
Board Certifications
  • American Board of Internal Medicine

Select Publications

2017

Odio, C. D., B. E. Marciano, J. N. Galgiani, and S. M. Holland, "Risk Factors for Disseminated Coccidioidomycosis, United States.", Emerg Infect Dis, vol. 23, issue 2, 2017 Feb. PMCID: PMC5324825  PMID: 28098554

2016

Narra, H. P., L. F. Shubitz, A. M Mandel, H. T. Trinh, K. Griffin, A. S. Buntzman, J. A. Frelinger, J. N. Galgiani, and M. J. Orbach, "A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.", Infect Immun, vol. 84, issue 10, pp. 3007-16, 2016 Oct. PMCID: PMC5038059  PMID: 27481239
Galgiani, J. N., N. M. Ampel, J. E. Blair, A. Catanzaro, F. Geertsma, S. E. Hoover, R. H. Johnson, S. Kusne, J. Lisse, J. D. MacDonald, et al., "Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.", Clin Infect Dis, vol. 63, issue 6, pp. 717-22, 2016 Sep 15. PMID: 27559032
Noble, J. A., R. G. Nelson, G. D. Fufaa, P. Kang, S. Chani Shafir, and J. N. Galgiani, "Effect of Geography on the Analysis of Coccidioidomycosis-Associated Deaths, United States.", Emerg Infect Dis, vol. 22, issue 10, pp. 1821-3, 2016 Oct. PMCID: PMC5038404  PMID: 27649029

2015

Martirosyan, N. L., J. M. Skoch, O. Zaninovich, C. Zoccali, J. N. Galgiani, and A. A. Baaj, "A paradigm for the evaluation and management of spinal coccidioidomycosis.", Surg Neurol Int, vol. 6, pp. 107, 2015. PMCID: PMC4483783  PMID: 26167359